To identify possible electroencephalographic (EEG) markers of donepezil's effect on cortical activity in young, healthy adult volunteers at the group level. METHODS: Thirty subjects were administered a daily dose of either 5mg donepezil or placebo for 15days in a double-blind, randomized, cross-over trial. The electroencephalogram during an auditory oddball paradigm was recorded from 58 scalp electrodes. Current source density (CSD) transformations were applied to EEG epochs. The event-related potential (ERP), inter-trial coherence (ITC: the phase consistency of the EEG spectrum) and event-related spectral perturbation (ERSP: the EEG power spectrum relative to the baseline) were calculated for the target (oddball) stimuli. RESULTS: The donepezil and placebo conditions differed in terms of the changes in delta/theta/alpha/beta ITC and ERSP in various regions of the scalp (especially the frontal electrodes) but not in terms of latency and amplitude of the P300-ERP component. CONCLUSION: Our results suggest that ITC and ERSP analyses can provide EEG markers of donepezil's effects in young, healthy, adult volunteers at a group level. SIGNIFICANCE: Novel EEG markers could be useful to assess the therapeutic potential of drug candidates in Alzheimer's disease in healthy volunteers prior to the initiation of Phase II/III clinical studies in patients.

A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers / Leroy, C; Bourriez, Jl; Dujardin, K; Molaee Ardekani, B; Babiloni, Claudio; Deplanque, D; Ponchel, A; Hennion, S; Plomhause, L; Devanne, H; Deguil, J; Payoux, P; Blin, O; Méligne, D; Micallef, J; Chauveau, N; Lanteaume, L; Vervueren, C; Guimont, F; Thalamas, C; Cassé Perrot, C; Rouby, F; Bordet, R; Derambure, P.. - In: CLINICAL NEUROPHYSIOLOGY. - ISSN 1388-2457. - 130:5(2019), pp. 863-875. [10.1016/j.clinph.2015.11.018]

A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers

BABILONI, CLAUDIO;
2019

Abstract

To identify possible electroencephalographic (EEG) markers of donepezil's effect on cortical activity in young, healthy adult volunteers at the group level. METHODS: Thirty subjects were administered a daily dose of either 5mg donepezil or placebo for 15days in a double-blind, randomized, cross-over trial. The electroencephalogram during an auditory oddball paradigm was recorded from 58 scalp electrodes. Current source density (CSD) transformations were applied to EEG epochs. The event-related potential (ERP), inter-trial coherence (ITC: the phase consistency of the EEG spectrum) and event-related spectral perturbation (ERSP: the EEG power spectrum relative to the baseline) were calculated for the target (oddball) stimuli. RESULTS: The donepezil and placebo conditions differed in terms of the changes in delta/theta/alpha/beta ITC and ERSP in various regions of the scalp (especially the frontal electrodes) but not in terms of latency and amplitude of the P300-ERP component. CONCLUSION: Our results suggest that ITC and ERSP analyses can provide EEG markers of donepezil's effects in young, healthy, adult volunteers at a group level. SIGNIFICANCE: Novel EEG markers could be useful to assess the therapeutic potential of drug candidates in Alzheimer's disease in healthy volunteers prior to the initiation of Phase II/III clinical studies in patients.
2019
donepezil; EEG markers; event-related potential; inter-trial coherence; event-related spectral perturbation
01 Pubblicazione su rivista::01a Articolo in rivista
A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers / Leroy, C; Bourriez, Jl; Dujardin, K; Molaee Ardekani, B; Babiloni, Claudio; Deplanque, D; Ponchel, A; Hennion, S; Plomhause, L; Devanne, H; Deguil, J; Payoux, P; Blin, O; Méligne, D; Micallef, J; Chauveau, N; Lanteaume, L; Vervueren, C; Guimont, F; Thalamas, C; Cassé Perrot, C; Rouby, F; Bordet, R; Derambure, P.. - In: CLINICAL NEUROPHYSIOLOGY. - ISSN 1388-2457. - 130:5(2019), pp. 863-875. [10.1016/j.clinph.2015.11.018]
File allegati a questo prodotto
File Dimensione Formato  
Leroy_A-15-day_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 3.52 MB
Formato Adobe PDF
3.52 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/954421
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact